Study Objective: To assess the incidence of pulmonary hypertension (PH) in patients with chronic myeloproliferative disorders (CMPD).
Method: Twenty-seven patients with a diagnosis of CMPD were included in the study. Patients were excluded if they had a secondary cause of PH.